These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23568706)

  • 1. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Gu F; Ma N; Zhang L; Bian JM; Cao HY
    Tumour Biol; 2013 Aug; 34(4):2309-13. PubMed ID: 23568706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Xu P; Yao J; He J; Zhao L; Wang X; Li Z; Qian J
    Oncotarget; 2016 Mar; 7(12):14831-40. PubMed ID: 26894380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M
    Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma.
    Chen DW; Fan YF; Li J; Jiang XX
    Tumour Biol; 2013 Jun; 34(3):1553-7. PubMed ID: 23400716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
    Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY
    Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.
    Zhao ZK; Wu WG; Chen L; Dong P; Gu J; Mu JS; Yang JH; Liu YB
    Tumour Biol; 2013 Jun; 34(3):1473-7. PubMed ID: 23355337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
    Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
    Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer.
    Masugi Y; Yamazaki K; Hibi T; Aiura K; Kitagawa Y; Sakamoto M
    Hum Pathol; 2010 Aug; 41(8):1061-8. PubMed ID: 20413143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression.
    Wu Y; Gu TT; Zheng PS
    Cancer Lett; 2015 Jan; 356(2 Pt B):646-55. PubMed ID: 25458953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
    Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
    Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
    World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of vasculogenic mimicry, PRRX1, and CIP2A in clear cell renal cell carcinoma and its clinicopathological significance.
    Wang X; Yang R; Wang Q; Wang Y; Ci H; Wu S
    Medicine (Baltimore); 2019 Sep; 98(36):e17028. PubMed ID: 31490389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.